Parotid gland mean dose as a xerostomia predictor in low-dose domains.

about

Design and Selection of Machine Learning Methods Using Radiomics and Dosiomics for Normal Tissue Complication Probability Modeling of Xerostomia.

P2860

Q55428458-44A56964-4416-4B79-BC31-9299A48D56FF

P2860

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

Item

http://www.wikidata.org/entity/Q48147430

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

@en

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

@nl

type

Item

label

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

@en

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

@nl

prefLabel

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

@en

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

@nl

P1476

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

@en

P2093

Florian Sterzing

http://www.w3.org/2001/XMLSchema#string

Henrik Hauswald

http://www.w3.org/2001/XMLSchema#string

Mark Bangert

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.

Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors.

Radiotherapy dose-volume effects on salivary gland function

Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.

Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience.

Patient-reported outcomes and the evolution of adverse event reporting in oncology.

P304

1197-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/0284186X.2017.1324209

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Florian Buettner

Hubert Szymon Gabryś

P577

2017-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28502238

http://www.w3.org/2001/XMLSchema#string

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

about

P2860

P2860

Parotid gland mean dose as a xerostomia predictor in low-dose domains.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698